Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Tormey

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Annual hazard rates of recurrence for breast cancer after primary therapyT Saphner, D C Tormey, R Gray
Medical and Pediatric Oncology|January 1, 1992
Continuous-infusion 5-fluorouracil combined with doxorubicin and cyclophosphamide: feasibility studyT Saphner, D C Tormey, P Carey
Journal of the National Cancer Institute|December 18, 1996
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology GroupD C Tormey, R Gray, H C Falkson
Canadian Medical Association Journal|March 17, 1973
Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinomaF H Stutz, D C Tormey, J Blom
Journal of Surgical Oncology|January 1, 1980
Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosineD C Tormey, T P Waalkes, C W Gehrke
Cancer Treatment Reports|October 1, 1977
Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancerD L Citrin, D C Tormey, P P Carbone
Cancer|June 1, 1977
Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophinD C Tormey, T P Waalkes, R M Simon
Cancer|October 1, 1975
Concurrent monoclonal IGM and IGA proteins in lymphocytic lymphomaD C Tormey, R R Ellison, D K Hossfeld
Cancer|February 1, 1978
The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulnessJ N Ingle, D C Tormey, H K Tan
Cancer Research|January 15, 1987
Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancerV C Jordan, N F Fritz, D C Tormey
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Annual hazard rates of recurrence for breast cancer after primary therapyT Saphner, D C Tormey, R Gray
Medical and Pediatric Oncology|January 1, 1992
Continuous-infusion 5-fluorouracil combined with doxorubicin and cyclophosphamide: feasibility studyT Saphner, D C Tormey, P Carey
Journal of the National Cancer Institute|December 18, 1996
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology GroupD C Tormey, R Gray, H C Falkson
Canadian Medical Association Journal|March 17, 1973
Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinomaF H Stutz, D C Tormey, J Blom
Journal of Surgical Oncology|January 1, 1980
Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosineD C Tormey, T P Waalkes, C W Gehrke
Cancer Treatment Reports|October 1, 1977
Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancerD L Citrin, D C Tormey, P P Carbone
Cancer|June 1, 1977
Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophinD C Tormey, T P Waalkes, R M Simon
Cancer|October 1, 1975
Concurrent monoclonal IGM and IGA proteins in lymphocytic lymphomaD C Tormey, R R Ellison, D K Hossfeld
Cancer|February 1, 1978
The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulnessJ N Ingle, D C Tormey, H K Tan
Cancer Research|January 15, 1987
Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancerV C Jordan, N F Fritz, D C Tormey
Pageof 14